Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-07-25

Clinical Trial Update: Pertussis Vaccine in Healthy Pregnant Women [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating a pertussis-containing vaccine in healthy pregnant women has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tdap vaccine (Diphtheria, tetanus, and pertussis vaccine (Tdap))

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Diphtheria, Pertussis | Phase 1 | Status: COMPLETED